Largest Biotechnology companies in Sweden by Market Capitalization

This ranking features the largest 62 Biotechnology companies in Sweden ranked by Market Capitalization, totaling a Market Capitalization of USD 36.01 B, for July 03, 2025.

#	Name	Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Sweden has the highest Market Capitalization ?

The Biotechnology company in Sweden with the highest Market Capitalization is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 10.34 B.

Which Biotechnology company in Sweden has the lowest Market Capitalization ?

The Biotechnology company in Sweden with the lowest Market Capitalization is Fluicell AB (publ) (Stockholm Stock Exchange: FLUI.ST) at USD 1.22 M.

What are the top 10 Biotechnology companies in Sweden by Market Capitalization ?

The top 10 Biotechnology companies in Sweden by Market Capitalization are Swedish Orphan Biovitrum AB (publ), Medicover AB (publ), Camurus AB (publ), AddLife AB (publ), Vimian Group AB (publ), Vitrolife AB (publ), Bonesupport Holding AB (publ), BioArctic AB (publ), RaySearch Laboratories AB (publ) and Biotage AB (publ).

What are the bottom 10 Biotechnology companies in Sweden by Market Capitalization ?

The bottom 10 Biotechnology companies in Sweden by Market Capitalization are Fluicell AB (publ), Aptahem AB (publ), Scandinavian Real Heart AB (Publ), Prostatype Genomics AB (publ), Modus Therapeutics Holding AB (publ), Scandinavian ChemoTech AB (publ), Qlife Holding AB (publ), Carbiotix AB, CombiGene AB (publ) and Newbury Pharmaceuticals AB (publ).